FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Senseonics Prices $41 Million Underwritten Offering of Common Stock May 25, 2017 Nestle's Galderma Laboratories to Slash Up to 450 Jobs at R&D Center September 20, 2017 <b>Revon Systems</b> Working With To Build Next Generation Clinical Algorithms September 6, 2017
